Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS · Delayed Price · Currency is USD
0.6950
0.00 (0.00%)
May 20, 2026, 9:30 AM EST
Mosaic ImmunoEngineering Market Cap
Mosaic ImmunoEngineering has a market cap or net worth of $5.03 million as of May 21, 2026. Its market cap has increased by 18.16% in one year.
Market Cap
5.03M
Enterprise Value
6.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.69
Market Cap Chart
Since October 15, 2020, Mosaic ImmunoEngineering's market cap has increased from 1.69M to 5.03M, an increase of 198.47%. That is a compound annual growth rate of 21.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 5.03M | 123.41% |
| Dec 31, 2025 | 2.25M | -55.65% |
| Dec 31, 2024 | 5.08M | 16.87% |
| Dec 29, 2023 | 4.35M | -39.39% |
| Dec 30, 2022 | 7.17M | -2.75% |
| Dec 31, 2021 | 7.37M | 181.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synlogic | 7.72M |
| Brainstorm Cell Therapeutics | 7.61M |
| BetterLife Pharma | 7.26M |
| TRON Group | 7.18M |
| Nymox Pharmaceutical | 5.41M |
| Adaptimmune Therapeutics | 5.30M |
| Reviva Pharmaceuticals Holdings | 5.25M |
| Institute of Biomedical Research | 5.22M |